Premium Nahrungsergänzungsmittel | artgerecht

Intestinal Villus Markers – Stool Diagnostics Explained

Intestinal villus markers are diagnostic parameters measured in stool samples that reflect the condition of the small intestinal villi and mucosal integrity. They support early detection of intestinal damage.

Regular tips about health Regular tips about health

Things worth knowing about "Intestinal Villus Markers (Stool)"

Intestinal villus markers are diagnostic parameters measured in stool samples that reflect the condition of the small intestinal villi and mucosal integrity. They support early detection of intestinal damage.

What Are Intestinal Villus Markers?

Intestinal villus markers (also referred to as stool villus markers) are biochemical parameters detectable in stool samples that provide information about the functional and structural condition of the intestinal villi (villi intestinales). The intestinal villi are finger-like projections of the small intestinal mucosa that play a critical role in nutrient absorption. When these structures are damaged, specific enzymes and proteins are released in elevated amounts into the stool.

Which Markers Are Measured?

The most clinically relevant intestinal villus markers include:

Fecal sucrase: Sucrase is an enzyme produced exclusively in mature enterocytes at the tips of the intestinal villi. Reduced levels indicate a loss of functional villus epithelial cells.
Fecal lactase: Lactase is another brush-border enzyme. Decreased stool levels may indicate damage to the small intestinal mucosa and complement standard lactase activity testing.
Alpha-1-antitrypsin (Alpha-1-AT): Elevated fecal concentrations suggest protein loss through the intestinal wall (protein-losing enteropathy), which is frequently associated with villus damage.
Intestinal fatty acid-binding protein (I-FABP): Released when enterocytes are injured, I-FABP is a sensitive marker of intestinal epithelial cell loss.

Clinical Significance and Applications

Intestinal villus markers are used in the evaluation of the following conditions:

Celiac disease (gluten-sensitive enteropathy): Untreated celiac disease causes characteristic villus atrophy. Fecal markers such as sucrase can serve as supplementary non-invasive parameters for monitoring disease progression.
Crohn disease and ulcerative colitis: Chronic inflammatory bowel diseases can permanently damage the intestinal mucosa, resulting in altered marker concentrations.
Short bowel syndrome: Following surgical bowel resection, villus markers reflect the remaining absorptive capacity of the intestine.
Malabsorption syndromes: General digestive and absorptive disorders can be objectively assessed using these markers.
Therapy monitoring: Follow-up assessments under a gluten-free diet or medical treatment are feasible using these markers.

Diagnosis and Test Procedure

Intestinal villus markers are determined from a stool sample collected at home by the patient and submitted to a specialized laboratory. The sample is analyzed for specific enzyme activities and protein concentrations. These markers are typically measured as part of a comprehensive stool diagnostics panel alongside inflammatory markers such as calprotectin or zonulin.

Reference Ranges

Reference ranges vary depending on the laboratory and analytical method used. Abnormal values should always be interpreted in the clinical context and in conjunction with additional diagnostic measures such as small bowel biopsy or blood tests.

Advantages of Stool-Based Diagnostics

The non-invasive nature of intestinal villus marker testing is a key advantage over endoscopy with biopsy. This approach is particularly beneficial for children or for monitoring the course of chronic diseases, offering a comfortable and patient-friendly alternative. However, stool markers do not replace endoscopic or histological examination in cases of diagnostic uncertainty.

References

Schulzke J.D., Ploeger S., Amasheh M. et al. - Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci. 2009;1165:294-300. PubMed PMID: 19538319.
Volta U., Villanacci V. - Celiac disease: diagnostic criteria in progress. Cell Mol Immunol. 2011;8(2):96-102. PubMed PMID: 21278765.
Rao J.N., Wang J.Y. - Regulation of gastrointestinal mucosal growth. Morgan and Claypool Life Sciences; 2010. Chapter 3.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.